Compare DHX & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DHX | PLX |
|---|---|---|
| Founded | 1991 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 150.3M | 168.4M |
| IPO Year | 2007 | 1996 |
| Metric | DHX | PLX |
|---|---|---|
| Price | $3.80 | $2.22 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $6.25 | ★ $12.00 |
| AVG Volume (30 Days) | 176.9K | ★ 569.2K |
| Earning Date | 05-05-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.04 | ★ 0.22 |
| Revenue | ★ $127,826,000.00 | $52,744,000.00 |
| Revenue This Year | N/A | $36.81 |
| Revenue Next Year | $3.52 | N/A |
| P/E Ratio | $92.88 | ★ $9.18 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.44 | $1.34 |
| 52 Week High | $4.10 | $3.19 |
| Indicator | DHX | PLX |
|---|---|---|
| Relative Strength Index (RSI) | 58.63 | 62.05 |
| Support Level | $3.47 | $2.03 |
| Resistance Level | $4.01 | $2.42 |
| Average True Range (ATR) | 0.26 | 0.07 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 68.84 | 98.93 |
DHI Group Inc is a provider of software products, online tools, and services that deliver career marketplaces to candidates and employers in the United States. The company operates through two reportable segments: ClearanceJobs and Dice. Its brands enable recruiters and hiring managers to search, match, and connect with skilled technologists, particularly in technology and active government security clearance, while professionals find job opportunities, job advice, and personalized data. ClearanceJobs connects security-cleared professionals with employers in a secure environment and supports engagement through messaging and live video. Dice, which generates maximum revenue, is a destination for technology and engineering talent, offering job postings across a range of technology roles.
Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.